Vertex Pharmaceuticals (Mexico) Analysis
| VRTX Stock | MXN 8,150 42.60 0.53% |
Vertex Pharmaceuticals is overvalued with Real Value of 7303.28 and Hype Value of 8150.0. The main objective of Vertex Pharmaceuticals stock analysis is to determine its intrinsic value, which is an estimate of what Vertex Pharmaceuticals is worth, separate from its market price. There are two main types of Vertex Pharmaceuticals' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Vertex Pharmaceuticals' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Vertex Pharmaceuticals' stock to identify patterns and trends that may indicate its future price movements.
The Vertex Pharmaceuticals stock is traded in Mexico on Mexican Exchange, with the market opening at 08:30:00 and closing at 15:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Mexico. Vertex Stock trading window is adjusted to America/Mexico City timezone.
Vertex |
Vertex Stock Analysis Notes
About 97.0% of the company outstanding shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 0.41. Vertex Pharmaceuticals recorded earning per share (EPS) of 238.31. The entity had not issued any dividends in recent years. Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for treating cystic fibrosis. The company was founded in 1989 and is headquartered in Boston, Massachusetts. VERTEX PHARMACEUTICAL operates under Biotechnology classification in Mexico and is traded on Mexico Stock Exchange. It employs 3400 people. For more information please call MD FASN at 617 341 6100 or visit https://www.vrtx.com.Vertex Pharmaceuticals Investment Alerts
| Vertex Pharmaceuticals generated a negative expected return over the last 90 days | |
| Vertex Pharmaceuticals has high historical volatility and very poor performance | |
| Over 97.0% of the company outstanding shares are owned by institutional investors |
Vertex Market Capitalization
The company currently falls under 'Mega-Cap' category with a current market capitalization of 1.46 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Vertex Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Vertex Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Vertex Profitablity
Vertex Pharmaceuticals' profitability indicators refer to fundamental financial ratios that showcase Vertex Pharmaceuticals' ability to generate income relative to its revenue or operating costs. If, let's say, Vertex Pharmaceuticals is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Vertex Pharmaceuticals' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Vertex Pharmaceuticals' profitability requires more research than a typical breakdown of Vertex Pharmaceuticals' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.37 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.49 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.49. Technical Drivers
As of the 25th of December, Vertex Pharmaceuticals has the Coefficient Of Variation of (2,351), risk adjusted performance of (0.03), and Variance of 8.87. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Vertex Pharmaceuticals, as well as the relationship between them.Vertex Pharmaceuticals Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Vertex Pharmaceuticals middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Vertex Pharmaceuticals. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Vertex Pharmaceuticals Predictive Daily Indicators
Vertex Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Vertex Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Vertex Pharmaceuticals Forecast Models
Vertex Pharmaceuticals' time-series forecasting models are one of many Vertex Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Vertex Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Vertex Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Vertex Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Vertex shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Vertex Pharmaceuticals. By using and applying Vertex Stock analysis, traders can create a robust methodology for identifying Vertex entry and exit points for their positions.
Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for treating cystic fibrosis. The company was founded in 1989 and is headquartered in Boston, Massachusetts. VERTEX PHARMACEUTICAL operates under Biotechnology classification in Mexico and is traded on Mexico Stock Exchange. It employs 3400 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Vertex Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Balance Of Power Now
Balance Of PowerCheck stock momentum by analyzing Balance Of Power indicator and other technical ratios |
| All Next | Launch Module |
Additional Tools for Vertex Stock Analysis
When running Vertex Pharmaceuticals' price analysis, check to measure Vertex Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceuticals is operating at the current time. Most of Vertex Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vertex Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vertex Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.